| Abstract: | Following HB vaccine inoculation, neonates
developed immune response and gave a high anti-
HBs seroconversion rate (range 92-100%). The com-
parison of the 7.70L, (1/13) HB infectivity rate in the
vaccinated group with the 80'70 (8/10) in the placebo
group showed that HB vaccine is effective in inter
rupting maternal HBsAg carrier transmission* Since
there is neither HBsAg nor anti-HBc in vaccinated
neonates born to HBsAg-negativc mothers, we con
sider that the HB vaccine is safe to the neonates. |
